Перевести на Переведено сервисом «Яндекс.Перевод»

Database research on anti-aging

Database
Ophimal Physical And Mental Activity

Authors:

R. S. Wilson, World Health Organization.

History:

It is known for a long time that physical activity benefits health. That was Hippocrates who said that nothing exhausts an organism more than physical inactivity. That fact is confirmed by our everyday experience as well as scientific researches.

However, benefits of mental exercises, cognitive games and memory training were only hypothesized for a long time. However, in 2000s, neuroscientist from the University College of Irvine obtained convincing evidence that training improves brain health. Their investigations have shown that memory training, cognitive games and exercises have positive effect at neurons regeneration in human brain.

Example:

Scientists from the European Society of Cardiology’s have proved that only 15 minutes of physical exercises a day decrease risk of death in elderly people at 51%. The report covering the results of that research was read at EuroPRevent conference in 2015.

In 2013, the Neurology journal published a paper submitted by scientists of the Rush University Medical Center, Chicago. That paper claims that regular mental activity maintains memory in elderly age.

Description:

There is abundant scientific evidence that regular physical and mental activity effect positively at physical and mental health. Physical exercises positively influence specific aspects of metabolism.

World Health Organization (WHO) states that physical exercises is the best way for diseases prevention for elderly people as well as for young ones. According to WHO, physically active elderly people have lower indices of death from cardiologic, metabolic and some oncological diseases. They have biomarker profile which favour preventing the development of cardiovascular diseases and diabetes type 2, and help improving the health of bones. Physically active elderly people have also higher levels of functional health and cognitive function; they have lower risk of moderate and severe functional and role limitations.

Scientists believe that easy physical exercises for elderly people could be enough to decrise the risk of death substantially. Exercises could include active pacing, riding the bicycle, swimming and gymnastics. Furthermore, it was shown that people maintaining brain activity during the life by means of cognitive activity have lower level of β-amiloid protein that is believed to be one of the main reasons of Alzheimer’s desease.

Additions and Criticism:

Modern scientists concluded that elderly people need not only physical, but also mental exercises. Unfortunately, this fact is not given appropriate consideration in our country. Developmental exercises and games are necessary not only for preschool child, but also for elderly people. It should be recommended to all our elderly people that they to do gymnastics for body and mind!

Publications:

  • Hauer, Klaus, et al. «Intensive physical training in geriatric patients after severe falls and hip surgery." Age and ageing 31.1 (2002): 49–57.
  • Rydwik, Elisabeth, Kerstin Frändin, and Gunnar Akner. «Effects of physical training on physical performance in institutionalised elderly patients (70+) with multiple diagnoses." Age and Ageing 33.1 (2004): 13–23.
  • Toulotte, Claire, et al. «Effects of physical training on the physical capacity of frail, demented patients with a history of falling: a randomised controlled trial.«Age and ageing 32.1 (2003): 67–73.
  • Corbi, Graziamaria, et al. «Role of sirtuins, calorie restriction and physical activity in aging." Front Biosci (Elite Ed) 4 (2012): 768–778.
  • Maillot, Pauline, Alexandra Perrot, and Alan Hartley. «Effects of interactive physical-activity video-game training on physical and cognitive function in older adults." Psychology and aging 27.3 (2012): 589.
  • Hertzog, Christopher, et al. «Fit Body, Fit Mind?." Scientific American 24 (2015): 40–47.
  • Wilson, Robert S., et al. «Influence of late-life cognitive activity on cognitive health." Neurology 78.15 (2012): 1123–1129.


Nanotechnologies

Authors:

Norio Taniguchi, Eric Drexler, Robert Freitas

History:

Science doesn’t stay in one place. Nanotechnologies and nanomaterials have found their application in medicine. At the eve of XXI century, such direction as nanomedicine has appeared. Nowadays this direction is rapidly developing, many nanotechnologies are already approved and patented for application in the field of drug delivery, diagnostics and treatment of some diseases, tissue regeneration and others. 

Example:


Nanorobots and nanocomputers are the perfect examples of medical application of nanotechnologies.

 Nanorobots — are the microscopic nanomachines of the future; they posses a high sensitivity, accuracy, and they can «obediently» execute the commands from the supervisory computer. With the help of nanorobots it is possible to provide the assembling of molecules, and in vivo tissue regeneration. Nanorobots are controlled by nanocomputers, which are characterized by highly accurate computation and programming. 

Description:

Nowadays, nanodevices are used in the field of skin anti-aging. But that is just the beginning. Nanotechnologies have an unlimited potential. The technologies of drug delivery with the help of nanoparticles are highly accurate and they are directed at the highly specific target.

 It is very important for the treatment of aging-related and oncological diseases.
Currently, nanomatrices for regenerative medicine are widely used for in vitro tissue growing, but the technologies are improving and soon it will be possible to regenerate the organs and tissues directly in the human organism. 

Injection of nanorobots will allow physicians to look inside the human organism, and it will extremely improve the accuracy of diseases diagnostics. These devices will demonstrate all human problems on «the large screen.»

Nanochips are extensively developing with the aim to fight with such intractable diseases as epilepsy. Nanochips will allow to control the convulsive seizures, analyzing the brain signals.

Furthermore, nanotechnologies offer exciting possibilities for their application in the field of personalized medicine, medical monitoring of patients, prostheses controlling.

Additions and Criticism:

All the mentioned application prospects are very promising, but there are some concerns and problems associated with the use of nanoparticles in medicine.

First of all, it is necessary to create a completely inert particles, which will not cause the immune response, when they will be ingested into the organism, and they will not interact with the organism’s molecules. Secondly, scientists still can not solve the problem of nanorobots toxicity for the organism: experiments on animals do not provide a decisive answer. And finally, there is a risk of damage of biomolecules, membranes, and cells from the invasion of nanodevices. 

Despite these problems, we can say that nanomedicine — is a young and promising direction, and the elimination of negative consequences is about timing.

Publications:

  • Moghimi, S. Moein, and Z. Shadi Farhangrazi. «Nanomedicine and the complement paradigm." Nanomedicine: Nanotechnology, Biology and Medicine9.4 (2013): 458–460.
  • Krol, Silke, Rutledge Ellis-Behnke, and Piero Marchetti. «Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments." Maturitas 73.1 (2012): 61–67.
  • Saha, Moni. «Nanomedicine: promising tiny machine for the healthcare in future-a review." Oman medical journal 24.4 (2009): 242.
  • Singh, Neeraj, Courtney A. Cohen, and Beverly A. Rzigalinski. «Treatment of neurodegenerative disorders with radical nanomedicine." Annals of the New York Academy of Sciences 1122.1 (2007): 219–230.


Clinical aging biomarkers

Authors:

Andrjez Bartke, Luigi Ferrucci, Vincent Giampapa

History:

Scientists are trying to determine the most definite aging biomarkers. Thus, in the 80s of the last century, Olovnikov AM has noted the telomere shortening as a potential aging biomarker. Last years it was discovered a number of molecular biomarkers. For example, the scientists from King’s College London have first identified 22 molecular aging biomarkers in blood. And specialists from Stanford University School of Medicine have discovered some substances in blood of older mice. These substances caused the changes in brain of young animals, that are typical for the brain of old animals. The level of these substances increases with aging, and they appear to inhibit brain ability to produce the new neurones, which are important for memory formation and learning ability. The researchers from the University of Liverpool have created a new technique that will help other researchers to find genes, which are responsible for aging. They managed to identify genes in different tissues of humans and animals, which were exposed to multiple aging.

Example:

Scientists tend to make possible that fact when every person will be able to control aging process in their own organism. Currently about 100 possible aging biomarkers were proposed. In our country some clinical tests for some biomarkers are available: for example, the determination of biomarkers for some kinds of age-related and oncological diseases.

Description:

Aging biomarkers can be considered at four levels: physiological, cellular, molecular and chromosomal one. Physiological biomarkers include basic indicators of body functioning: eye and hearing examination, muscle mass, flexibility, aerobic endurance and others.

In order to determine the cellular aging biomarkers it should be taken a skin biopsy from the areas of skin, which seems to be in well condition. It is necessary to determine the quantity and quality of age-related changes in the structure of all skin layers: condition of epidermis and adipose glands, collagen content and skin elasticity.

At the molecular level it is possible to determine more definite aging biomarkers. To determine the molecular aging biomarkers it should be taken the analysis of key hormones: human growth hormone, thyroid hormone, Q10, insulin sensitivity, heat shock proteins, oncogene analysis, serum levels of antioxidants.

At the chromosomal level the aging biomarkers include determination of telomeres position and DNA degradation rate.
The scientists from the International Longevity Institute have developed the blood test, which will be able to monitor the DNA damage, and it will indicate the effect of anti-aging therapy at the DNA level.
Let’s talk more detail about some prospective aging biomarkers.

Human Growth Hormone

A possible aging biomarker is a growth hormone. It is well known that with aging the level of growth hormone decreases.
This decrease of growth hormone level is believed to be responsible for age-dependent accumulation of fat tissue, and loss of muscle tissue, as well as decrease of mineral content in bones. Therefore, it could be concluded that the reduced level of growth hormone leads to accelerated aging.

Thus, the members of Andrjez Bartke’s laboratory (Department of Physiology, Medical School, University of Southern Illinois) have obtained the data which show that the mice with impaired hypophysary function have longer lifespan, and overproduction of growth hormone lead to lifespan shortening.

AGE accumulation

AGE (glycation end products) can damage cells in different ways: functional impairment of proteins through modifications, cross-linking of proteins, induction of free radical formation, activation of immune response.
AGE accumulation was demonstrated on various kinds of tissues from patients suffered from diabetes. Moreover, the researchers from the Dr. Monnier’s laboratory (Cleveland, USA) have demonstrated that AGE accumulation could be used as a marker of early death of mice.

Increase of Interleukin-6

With aging the inflammatory cytokines are significantly activated. The examples are: Interleukin-6 (IL-6), tumour necrosis factor TNF-a, IL-1. At the same time the decrease of testosterone level in blood occurs.
Dr. Luigi Ferrucci (Department of Clinical Research Hospital in Harbour) has investigated a population of 473 elderly men and analyzed the interactions between level of testosterone and IL-6.

He has found out the dependence between the testosterone level and IL-6 receptor, which increases the activity of IL-6 cytokine. However, it was not found any relations with other inflammation markers. Meanwhile, other scientists have obtained the data about the relations between increased IL-6 expression with age-related cataracts; as well as relations between increase of mortality risk in the group of elderly men and increase of IL-6 levels.

Additions and Criticism:

Scientists have identified a number of aging biomarkers, but none of them are independent: only a set of markers can demonstrate a real aspect of aging. Separately none of biomarkers provide an exact forecast, mortality estimate or exactable lifespan, as well as a choice of the optimal therapeutic intervention to treat a particular disease. Therefore, researchers are trying to find more informative aging biomarkers to estimate the risk of disease development and to predict the disease outcome.

Publications:

  • McCarrey, Anna, et al. «Interleukin-6 (IL-6) is associated with longitudinal rates of cortical thinning." Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 9.4 (2013): P307.
  • Imbert, Isabelle. «Biomarkers and aging." Biomarkers in medicine 8.5 (2014): 621–623.
  • Zhang, Wei-Guang, et al. «Select aging biomarkers based on telomere length and chronological age to build a biological age equation." Age 36.3 (2014): 1201–1211.
  • Mishur, Robert J., and Shane L. Rea. «Applications of mass spectrometry to metabolomics and metabonomics: Detection of biomarkers of aging and of age‐related diseases." Mass spectrometry reviews 31.1 (2012): 70–95.

Induced Pluripotent Stem Cells (iPSC)

Authors:

Matthias Stadtfeld, Hongyan Zhou

History:

Obtaining of mammalian pluripotent stem cells from fibroblasts of adult animals became a real breakthrough in Cell Biology. Due to addition of transcription factors to fibroblasts, the cells of adult animals are able to transform into any cell of the organism. Such cells were called induced Pluripotent Stem Cells (iPSCs). In 2008 this experiment was first repeated in human cells.

Example:

On September 12, 2014 in Japan the 70-year-old patient with age-related degenerative changes of retina underwent the first operation on transplantation of retinal cells derived from iPSCs.

Description:

Pluripotent Stem Cells are able to transform into any type of adult organism cells. Induced Pluripotent Stem Cells — are the cells, driven from somatic cells of adult organism.

The obtaining technology of these cells is quite simple: in vitro the somatic cells are driven from a patient skin biopsy; then the cells are converted into iPSCs, and these «fresh» pluripotent cells are differentiated into the necessary cell type and, finally, they are transferred to the patient.
IPSCs are expected to give the opportunity to replace the sick or lost cells directly into the tissues, regenerating the body literally by cells. It will be suitable for the treatment of many diseases, such as Alzheimer’s, Parkinson’s, diabetes, and consequences of heart attack.

Furthermore, on the immortal iPSCs cultures it can be studied many rare genetic diseases, as well as developed and tested the methods to fight such diseases. iPSCs have already been obtained for the treatment of such diseases, as Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease), Rett syndrome, Spinal Muscular Atrophy (SMA), insufficiency of Antitrypsin α1, Familial Hypercholesterolemia, as well as for treatment of various cardiac diseases.

Additions and Criticism:

The downside of iPSCs application is a possibility of malignant transformation of this cells in the human organism. In addition, talking about brain diseases, there are a number of additional problems of iPSCs transplantation because of outstanding complexity of the human nervous system.

Despite potential concerns, nowadays, the iPS cells technology is one of the most promising methods for studying the molecular mechanisms of cellular abnormalities, as a part of personalized medicine; creation of the effective test systems for searching and screening of pharmaceutical preparations; and for the development of cell therapy approaches to treat various human diseases.

Publications:

  • Zhao, Tongbiao, et al. «Immunogenicity of induced pluripotent stem cells." Nature474.7350 (2011): 212–215.
  • Han, Dong Wook, et al. «Direct reprogramming of fibroblasts into neural stem cells by defined factors." Cell stem cell 10.4 (2012): 465–472.
  • Robinton, Daisy A., and George Q. Daley. «The promise of induced pluripotent stem cells in research and therapy." Nature 481.7381 (2012): 295–305.


Diet of Longevity (Caloric Restriction)

Authors:

C. M. McCay, R. Walford, R. Weindruch.

History:

In 1930s, C. M. McCay found in his researches that a dietary regimen that reduces calorie intake but maintains micronutrient levels resulted in the increase of the maximum and medium life spans of rats and mice 30–50%. Last years, this technology, due to its simplicity and stable reproducibility, has become one of the leading models in the investigations of fundamental mechanisms of aging and life extension.

Example:

A study of a lifespan was made by the University of Wisconsin in 1989 — 2014. It involved nonhuman primates (rhesus monkeys) and found that caloric restriction primates were only 36.4% as likely to die from age-related causes when compared with control animals, and had only 56.2% the rate of death from any cause.

Description:

Increasing evidence suggests that energy balance is central to both successful ageing and protection from metabolic disorders.
Energy restriction, also known as caloric restriction, is currently the only dietary intervention that is proven to increase longevity and delay the onset of age-related decline in a wide variety of organisms, including Caenorhabditis elegans, Saccharomyces cerevisiae, Drosophila melanogaster, rodents. Nevertheless, in primates CR appears to not affect longevity, but clearly delay age-associated disorders improving health.
Calorie restriction, or caloric restriction (CR), is a dietary regimen that is based on low calorie intake but without malnutrition. «Low» can be defined relative to the subject’s previous intake before intentionally restricting calories, or relative to an average person of similar body type.
Even though there has been research on CR for over 70 years, the mechanism by which CR works is still not well understood. Some explanations include reduced core body temperature, reduced cellular divisions, lower metabolic rates, reduced production of free radicals, reduced DNA damage and hormesis.

Additions and Criticism:

It should be noted that long-term calorie restriction at a level sufficient for slowing the aging process is generally not recommended in children, adolescents, and young adults (under the age of approximately 21), because this type of diet may interfere with natural physical growth and mental development. Pregnant women and women trying to become pregnant are advised not to practice calorie restriction, because it may result in ovulatory dysfunction (infertility), and underweight mothers are more prone to preterm delivery.

Publications:

  • Spindler, Stephen R., Joseph M. Dhahbi, and Patricia L. Mote. «Protein turnover, energy metabolism, aging, and caloric restriction." Advances in cell aging and gerontology 14 (2003): 69–86.
  • Ungvari, Zoltan, et al. «Mechanisms Underlying Caloric Restriction and Lifespan Regulation Implications for Vascular Aging." Circulation research 102.5 (2008): 519–528.
  • Mattison, Julie A., et al. «Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study." Nature (2012).
  • Willcox, Bradley J., et al. «Caloric restriction, the traditional Okinawan diet, and healthy aging." Annals of the New York Academy of Sciences 1114.1 (2007): 434–455.

Geroprotectors (anti-aging drugs)

Authors:

Anisimov v. N., Skulachev v. P., Moskalev A.A.

History:

The ancient philosophers did not want to put up with aging and death. And the ancient alchemists strived to create an elixir of immortality. People were looking for aids to make life longer, or at least to provide healthy aging. At first they used herbs and roots; and with the progress of Molecular Biology and Biotechnology, the scientists tended to fight aging at a molecular level. Therefore, up to date, it were discovered and studied more than 40 chemical geroprotectors.

Example:

Scientists have found that metformin and other biguanides reduce the total mortality rate by more than one third, as well as the mortality from heart attacks and complications from diabetes mellitus; improve the survival rate of cancer patients, and also reduce the risk of breast cancer in patients with type 2 diabetes.

Description:

Geroprotectors (anti-aging drugs) — a common name for a group of substances possessing the ability to increase the lifespan of experimental animals and human.

Up to date, it were discovered and studied more than 40 chemical geroprotectors with declared efficacy. Among them the most famous are resveratrol, rapamycin, protein biosynthesis inhibitors (olivomycin, actinomycin), hormones (growth hormone, thyroid hormones, adrenocortical hormones, reproductive hormones, melatonin), biguanides (metformin, phenformin and others).

Among the mentioned geroprotectors metformindeserves a special attention. The results of studies on mammalian have led to the hypothesis that hyperinsulinemia and hyperglycemia are very important factors both in aging process and in cancer development.

In clinical observations it was found that metformin and other biguanides reduce the total mortality by more than one third, as well as the mortality from heart attacks and complications from diabetes mellitus, improve the survival rate of cancer patients and also reduce the risk of breast cancer in patients with type 2 diabetes. In experiments on laboratory rodents it was discovered a geroprotective effect of antidiabetic medicines, accompanied with decreasing of frequency of spontaneous tumours development. In different models of chemical and radiation carcinogenesis it was found that biguanides are able to slowdown the induced tumours development, and inhibit the growth of many transplanted tumours. 

Additions and Criticism:

Most authors take the view that until now there is no one chemical geroprotector with incontestable proven effect.

Publications:

  • Anisimov, Vladimir N., et al. «If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice." Aging (Albany NY) 3.2 (2011): 148.
  • Morrison, John A., Elizabeth M. Cottingham, and Bruce A. Barton. «Metformin for weight loss in pediatric patients taking psychotropic drugs." American Journal of Psychiatry (2014).
  • Rattan, Ramandeep, et al. «Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo." Neoplasia 13.5 (2011): 483-IN28.

Epigenetic changes

Authors

This area of investigations is developing by a number of scientists, among them are A. D. de Grey, J. Vijg, R. Holliday et al.

History:

The history of epigenetic researches is linked with studies of evolution and development. For a long time, many scientists did not acknowledged epigenetics at all or even intentionally passed it over in silence. 

That occurred mainly due to the fact that knowledge about the nature of epigenetic signals and ways of their realization in the organism was very indistinct. Actually, epigenetics in modern interpretation was developing and promoting by scientists of our country — I. v. Michurin, F. D. Lysenko and their followers, and by some foreign researches, e.g. D. L. Nanney an investigator of the ciliated protozoa. It should be noted that understanding of the molecular mechanisms providing epigenetic regulation of gene expressing has come only at the beginning of 2000s.

Example:

Enzygotic twins are known to be clones, i.e. exact genetic copies of each other. In the early childhood, their chromosomes have nearly the same patterns of DNA methylation in the same tissues. Nevertheless, when such twins grow old, they have sharply different patterns of DNA methylation in spite of the genetic identity and the same age.

Description:

Though chromosomes are regularly damaging and the effectiveness of the repair mechanisms declines with age, mutations occur quite rare and slowly accumulate with age.

 But the frequency of cancer and other age-related diseases indicates that gene activity changes much faster. It was found that the other type of chromosome changes appears substantially more often and makes more valuable contribution in aging. That is epimutations, i.e. changes in gene activity which are not accompanied with changes in DNA sequence. Epimutations influence gene activation and deactivation via changs in the pattern of methyl labels set in various areas of genome. If the methyl label present at nucleotides of definite gene, that gene becomes silent. On the contrary, taking methyl labels away activates the gene. The organism needs those manipulations with DNA methylation to be able to create cells and tissues with different sets of active genes and proteins synthesized on the basis of the same genotype. Proteins and functions necessary for brain neurons are vain for liver cells, and vice versa. 

When we age, global demethylation of genome takes place, and that activates genes that must normally be «silent». Demethylation is provoked by chromosome damages, age-related decline in the activity of enzymes putting methyl label through genome, redundancy of homocysteine amino acid, insufficient level of sex hormones. On the contrary, some important genes, e.g. genes of receptors of sex hormones, genes of telomerase and DNA repair ungergo selective hypermethylation in some tissues. That sort of epimutations switch the function of the gene off. All in all, as we age, epimutations accumulate in different tissues in a random way and change activity of a number of genes (1 to 10%). Now we know that epimutations can cause cancer, atherosclerosis, coronary heart disease, diabetes and Alzheimer’s disease.

Additions and Criticism:

Life style (including the type of diet) and environment influence substantially the probability of demethylation. For example, deficiency in uptake of vitamins (folic acid, B12) and microelements (zinc, selenium) in old age is one of the reasons of demethylation.

It is not clear as yet why age-related hypermethylation occurs. But there is no doubt that if we are able to control the process of methylation, we will possess one of the approaches allowing to control aging.

Publications:

  • de Grey, Aubrey DNJ. «Protagonistic pleiotropy: why cancer may be the only pathogenic effect of accumulating nuclear mutations and epimutations in aging." Mechanisms of ageing and development 128.7 (2007): 456–459.
  • Vijg, Jan. «The role of DNA damage and repair in aging: new approaches to an old problem." Mechanisms of ageing and development 129.7 (2008): 498–502.
  • Gravina, Silvia, and Jan Vijg. «Epigenetic factors in aging and longevity." Pflügers Archiv-European Journal of Physiology 459.2 (2010): 247–258.
  • Holliday, Robin. «Perspectives in aging and epigenetics." Epigenetics of Aging. Springer New York, 2010. 447–455.


Chronic stress

Authors:

The understanding of this mechanism of aging is expanding owing to the works of such scientists as P. W. Landfield, A. K. Zalta, K. K. Wong, S. J. Lupien. et al.

History:

Our current use of the term stress originated only a little more than 50 years ago. This term was borrowed from the field of physics by one of the fathers of stress research H. Selye. H. Selye began using the term stress in the 1920’s. H. Selye pioneered the field of stress research and provided convincing arguments that stress impacted health. From the late 1960s, a large amount of research was undertaken to examine links between stress and disease of all kinds. By the late 1970s, stress had become the medical area of greatest concern. There was also a great amount of laboratory researches into the neuroendocrine, molecular, and immunological bases of stress. By the 1990s, «stress» had become an integral part of modern scientific understanding in all areas of physiology and human functioning, and one of the great metaphors of Western life.

Example:

Old people have increased level of the stress hormone cortisol. Under stress, that essential hormone increases sugars (glucose), amino acids and lipids in the bloodstream, suppresses inflammatory processes. 

At the same time, if the concentration of cortisol is heightened for a long period of time, that can disturb nourishment of tissues, cause arterial hypertension and suppress functions of hippocampus (that is brain region responsible for the memory). As the result, old people often have weak memory, reduced learning capability, increased irritability and increased susceptibility to depression.

Description:

Stress is a nonspecific organism’s response to a stressor (any action that causes imbalance in the stability of internal conditions). Factors favouring emergence of stress in an organism are quite numerous. They can be external (exogenous): increased or decreased environment temperature, fluctuations of oxygen concentrations in the air, injuries, hypodynamia, infections, excess or lack of nutrients, toxins, chemical mutagens, ionizing radiation and untraviolet. They can also be internal (endogenous): the psychological, neurohormonal, oxidative stress, mitochondrial stress and the stress of the endoplasmic reticulum.

By rights aging may truly be called the chronic stress. During aging more and more physiological constants of our body go beyond acceptable limits. Failure of constancy is clearly seen in the deviation of blood indeces from norma — it concerns blood pH, levels of glucose and other nutrients, amount of lipoproteins of various classes, concentrations of vitamins, macro- and microelements. The deviation of the parameters mentioned above causes activation of compensatory processes, and the latter frequently cause more damages than deviation on its own.

Additions and Criticism:

Recent researches made at the Harvard Medical School have revealed the physiological mechanism binding chronic stress and acute dysfunction of cardiovascular system. It was found that prolonged stress trigger the cascade of reactions which result in excess production of leukocytes — cells of immune system which accumulate in arteries and cause formation of complicated, rupture-prone atherosclerotic plaques. Finally, that provokes stroke.

Publications:

  • Kerr, D. Steven, et al. «Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging." The Journal of neuroscience 11.5 (1991): 1316–1324.
  • Simon, Naomi M., et al. «Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging." Biological psychiatry 60.5 (2006): 432–435.
  • Juster, Robert-Paul, Bruce S. McEwen, and Sonia J. Lupien. «Allostatic load biomarkers of chronic stress and impact on health and cognition." Neuroscience & Biobehavioral Reviews 35.1 (2010): 2–16.
  • Kiecolt-Glaser, Janice K., et al. «Chronic stress and age-related increases in the proinflammatory cytokine IL-6." Proceedings of the national Academy of Sciences 100.15 (2003): 9090–9095.

Disorders of the internal clock

Authors:

This mechanism of aging is investigated by v. Pouthas, M. J. Allman, O. v. Reeth et al.

History:

The earliest known account of a circadian process dates from the 4th century BC, when Androsthenes, a ship captain serving under Alexander the Great, described diurnal leaf movements of the tamarind tree. The observation of a circadian or diurnal process in humans is mentioned in Chinese medical texts dated to around the 13th century. The first recorded observation of an endogenous circadian oscillation was by the French scientist J.-J. d’Ortous de Mairan in 1729 when he studied the movement of the leaves of the plant Mimosa pudica. In 1918, J. S. Szymanski showed that animals are capable of maintaining 24-hour activity patterns in the absence of external cues such as light and changes in temperature. R. Konopka and S. Benzer isolated the first clock mutant in Drosophila in the early 1970s and mapped the «period» gene, the first discovered genetic component of a circadian clock. Joseph Takahashi discovered the first mammalian «clock gene» using mice in 1994. The term «circadian» was coined by F. Halberg in the late 1950s.

Example:

Disorders of the internal clock predispose our organism to system inflammation, cancer, cardiovascular diseases, metabolic syndrome and diabetes, neurodegenerative, cognitive and sleep disorders.

Some acute pathologies like hypertensic crisis, myocardial infarction, attacks of asthma and allergy are sometimes linked to the definite day hours.

Description:

Internal body clock, or circadian rhythms are the cyclic oscillation of the intensity of various biological processes which is linked to alternation of day and night. Although circadian rhythms are connected with external stimuli, they have endogenous origin. The central (in the brain) and peripheral (in liver, lungs, heart, kidneys, skin) internal body clocks play important role in the regulation of the metabolism, sleep/wake cycles, rhythmicity of the hormones secretion, physical activity, intestinal peristalsis, body temperature, arterial pressure and levels of various metabolites in the blood.

Circadian rhythms disorders cause oxidative stress, disorders in synthesis of regulatory and other proteins, lead to inflammatory processes, insensibility to insulin, hormonal disbalance. Mistiming between the internal clock and environmental signals leads to the onset of the symptoms of tiredness, disorientation, sleeplessness, as well as to deterioration in the general level of health.

Additions and Criticism:

Tests on laboratory animals have shown that the activity of key genes controlling circadian rhythms comes down as an individual grows older. Thus, mice with mutations reducing activity of the key genes mentioned above live substantially less than normal animals. At the same time, artificial activation of some of those genes in the muscle tissue of mice leads to lifespan extension. Similar results were obtained in researches on fruit flies.

Finally, we can resume that circadian rhythms disorders conform with three characteristics of the criterion acceptable for aging detection: their appearance may be observed at the early stage of aging; such disorders promote aging; but if we prevent them, aging may be delayed.

Publications:

  • Baudouin, Alexia, et al. «Differential involvement of internal clock and working memory in the production and reproduction of duration: A study on older adults." Acta Psychologica 121.3 (2006): 285–296.
  • Allman, Melissa J., et al. «Properties of the internal clock: first-and second-order principles of subjective time." Annual review of psychology 65 (2014): 743–771.
  • Perbal, Séverine, et al. «Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson’s disease." Brain and cognition 58.1 (2005): 35–48.
  • Turek, Fred W., et al. «Effects of age on the circadian system." Neuroscience & Biobehavioral Reviews 19.1 (1995): 53–58.

Metabolic decline

Authors:

Researches on this mechanism of aging are carrying out intensively by A. Bartke, D. A. Sinclair, J. E. Brown et al.

History:

The history of researches on the metabolism covers several centuries. At present, metabolic diseases associated with aging are actively investigated. The purpose of those investigations is improvement of the life quality and development of methods allowing to increase human life span. 

Example:

Alterations of cell metabolism during aging, especially energy generation pathways often result in disease or acceleration of the aging process, namely diabetes, fatty liver disease, cardiovascular diseases, infertility and cancer.

Description:

Metabolism is a term that is used to describe all chemical reactions involved in maintaining the living state of the cells and the organism.

The aging process is characterized by progressive metabolic decline over time, namely by insulin resistance, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.

Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus, cardiovascular disease, and stroke. Insulin resistance represents a major component of metabolic syndrome and is commonly observed in older adults. Major impairments include unrestrained hepatic gluconeogenesis, adipose lipogenesis, and defective glycogen synthesis and glucose uptake in skeletal muscle. Abdominal obesity, which is commonly observed with aging, is a major contributor metabolic syndrome.

Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action. These cytokines are derived from both the age-associated accrual of visceral fat and secretion of proinflammatory cytokines by increasing numbers of senescent cells. Collectively, these age-related alterations in metabolism and body fat distribution can accelerate the aging process and the onset of disease.

Additions and Criticism:

Results of researches made on experimental animals and human demonstrated that the process of aging is accompanied by changes in the ability of an organism to regulate water and electrolyte (mainly, sodium) balance. 

Generally, dehydratation of tissues, hypo- or hypernatremia take place, and mineral balance becomes negative. Moreover, elderly people are much more sensitive to the changes of that balance than young ones.

Imbalance of minerals (e.g. calcium and magnesium) observed as we age promotes osteoporosis. That imbalance is associated with age-related disorders of intestinal uptake of minerals and vitamin D, and changes in renal functioning. Magnesium deficiency can cause additional decrease in melatonin production making sleep quality worse.

Publications:

  • Barzilai, Nir, et al. «The critical role of metabolic pathways in aging." Diabetes 61.6 (2012): 1315–1322.
  • Rana, Karan S., et al. «The interaction between metabolic disease and ageing." Global journal of obesity, diabetes and metabolic syndrome 1.1 (2014).
  • Wu, Lindsay E., Ana P. Gomes, and David A. Sinclair. «Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis." Cancer cell 25.1 (2014): 12–19.

1 ... 10 11 12 ... 24